Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 527 results found. Search for [ covid-19 human trials ]

Results 60 to 80 of 527
PTI
December 19, 2020
Authorisation by the MHRA will also give confidence to countries across the world. India has already manufactured more than 50 million of the AstraZeneca vaccines, the newspaper notes


BusinessToday.In
December 18, 2020
In India, RDIF has tied up with Dr Reddy's Laboratories for trials and regulatory approvals. Dr Reddy's recently began phase-2 and 3 clinical trials after getting requisite clearance


Reuters
December 18, 2020
COVID-19 hospitalisations mounted as U.S. regulators weighed whether to grant emergency use authorization for a vaccine developed by Moderna Inc


PTI
December 16, 2020
US pharmaceutical giant Pfizer began shipping the first batches of its long-awaited and newly-authorised coronavirus vaccine out of a Michigan warehouse on Sunday, setting in motion the biggest vaccination drive in American history


BusinessToday.In
December 16, 2020
Last month, 67-year-old Anil Vij volunteered himself for Bharat Biotech's coronavirus vaccine trial. The firebrand BJP leader had offered to be the first volunteer in the phase three trials for Covaxin


PTI
December 16, 2020
The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said


BusinessToday.In
December 14, 2020
Calculation was based on the analysis of data of volunteers who received both the first and second doses of the Sputnik V vaccine or placebo at the third and final control point of 78 confirmed cases in accordance with the Phase III clinical trials protocol


BusinessToday.In
December 13, 2020
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) sought additional safety and efficacy data for COVID-19 vaccine candidates of Bharat Biotech after deliberating upon its applications seeking emergency use authorisation for the shots


Reuters
December 13, 2020
The U.S. aviation regulator said pilots and controllers must not fly or conduct safety-related duties for 48 hours after receiving doses


Reuters
December 12, 2020
 India readies for 60 crore doses of Covid-19 vaccines to be administered to the most vulnerable people through conventional cold chain systems, says top government expert


PB Jayakumar
December 11, 2020
As the country plans to vaccinate 30 crore people by July in the first phase, it may be difficult to bank alone on the Indian vaccines, especially Serum Institute's (SII) Covishield


BusinessToday.In
December 11, 2020
The mRNA vaccine candidate -  HGCO19 - is being developed by Pune-based company Gennova, and is supported with seed grant under the Ind-CEPI mission of Department of Biotechnology under Ministry of Science and Technology


BusinessToday.In
December 11, 2020
The researchers said in an article published by the journal Plos One that dogs can confirm the presence of the virus by sniffing samples of human sweat


BusinessToday.In
December 11, 2020
The regulatory approval in the UK is crucial to strengthen SII's application seeking emergency use authorisation in India because the proposal here refers to trials being conducted in the UK and Brazil


BusinessToday.In
December 10, 2020
The Subject Expert Committee (SEC), a government panel tasked with vetting coronavirus vaccines, has asked Bharat Biotech and Serum Institute of India (SII) to submit updated country-specific trial data of their vaccine candidates Covaxin and Covishield


PTI
December 8, 2020
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation


BusinessToday.In
December 7, 2020
After American drug maker Pfizer and Pune-based Serum Institute, Bharat Biotech is the third company to apply for emergency use authorisation for its COVID-19 vaccine to the DCGI


BusinessToday.In
December 7, 2020
As per the Indian Council of Medical Research (ICMR), Serum Institute has manufactured four crore doses of the vaccine under the at-risk manufacturing and stockpiling licence obtained from the DCGI


BusinessToday.In
December 4, 2020
Study says anti-bodies declined slightly over time but remained elevated in all participants even 3 months after vaccination. NIAID director Anthony Fauci and other infectious diseases experts say it is possible that our bodies would remember virus and produce more anti-bodies if exposed to the virus again


BusinessToday.In
December 3, 2020
Serum Institute's chief executive officer, Adar Poonawalla, has confirmed that the company's coronavirus vaccine will enter the open market post-March to April 2021 if the vaccine is found to be 'immunogenic and safe'


PAGES 4 OF 27  12345